Search results

This study has aimed to analyse the role of innovation-sharing collaboration in the large-scale manufacturing of Covid-19 vaccination across the globe and its impact on the mortality rate of the countries where the pharmaceutical manufacturers received such innovation.

The authors have relied upon the difference-in-difference (DID) approach by utilizing the data available on public platforms such as World Health Organization (WHO) databank, organization for economic co-operation and development (OECD) data bank, istat, Indian bureau of statistics and European centre for disease prevention and control (ecdc) from 2020 to 2021 to establish the empirical inference of the analysis.

This study’s results present that after the invention and commercialization of the vaccine, the Covid-19 impact was still intact and people were dying continuously. However, it was impossible to fulfil the demand of the 7 billion population in a short time. In the light of these facts, the WHO encouraged sharing vaccine innovation with other countries to enhance production capacity. The authors found that after vaccine innovation sharing, Covid-19’s devastation slowed: the fatality rate was marginally reduced, and economic conditions started their recovery journey.

This study’s findings present that the Covid-19 vaccine played a pivotal role in tackling the Covid-19’s devastating impact on the entire world. It emphasizes the role of innovation-sharing collaborations in curtailing hazardous consequences, including the mortality rate during a crisis, and such collaborations’ impact on the countries where institutions involved in them reside.

This paper aims to examine the effect of R&D laboratories on the perceived performance of MNE subsidiaries during recession.

Employing resource-based view and knowledge-based theory, the authors investigate a unique sample of 171 technologically heterogenous foreign MNE subsidiaries located in Greece over the period of recession 2009–2016. The sample subsidiaries operate different types of R&D laboratories.

The authors find that MNE subsidiaries with advanced R&D laboratories such as locally integrated laboratories (LILs) and internationally interdependent laboratories (IILs) perform better in recession than subsidiaries with support laboratories (SLs) or subsidiaries without R&D laboratories. Overall, the authors find an asymmetric performance contribution of R&D laboratories at subsidiary level.

The study provides useful insights into the environmentally derived “knowledge-based - performance” context, so filling an important research gap, since little is known about the performance impact of the input-side of technological activity at MNE subsidiary level, especially as regards R&D facilities/infrastructure. Based on the findings the authors identify important managerial implications.

Scholars of business, economics, and law have long recognized that rights to intellectual property (IP) intimately shape innovative activity and the pursuit of profits. More than 60 years ago, Michal Polanyi voiced the following concerns about awarding property rights to creations of the “intellect”:The law…aims at a purpose which cannot be rationally achieved. It tries to parcel up a stream of creative thought into a series of distinct claims, each of which is to constitute the basis of a separately owned monopoly. But the growth of human knowledge cannot be divided into such sharply circumscribed phases. Ideas usually develop gradually by shades of emphasis, and even when, from time to time, sparks of discovery flare up and suddenly reveal a new understanding, it usually appears that the new idea has been at least partly foreshadowed in previous speculations. (Polanyi, 1944, pp. 70–71)

This SWOT (strengths, weaknesses, opportunities and threats) analysis was conducted to have a portrait of the competitiveness of Council of Scientific and Industrial Research (CSIR) on the global map. Being a 75-year-old scientific organization, CSIR has raised each and every laboratory with a specific mandate and competency. It is definite that the organization would get some assistance from these points, which are briefly stated, as the institutional data reside with the laboratory only. To some extent, they can be considered on their discretion; however, the organization has raised its position to international standards, but still it can consider few areas/suggestions from this analysis. These points are suggestive and flexible in nature, which are identified and defined to elevate this organization on the globe. Scientific publications do make a difference, but on the ground, if the technologies are not viable and received by public, it makes no difference. Today, India is fortunate to have a Prime Minister like Mr Modi, who always re-evaluates the issues and solutions so that the country moves from developing to a fast-pace developed nation. It is a fact that if these research organizations reorganize themselves and prioritize the research problems, they are capable enough to become a pioneer among the world R&D industry. This paper aims to analyze the organization and suggest few points with significant findings which can assist in scaling toward excellence on a global scale.

On the basis of random sampling, laboratories were identified where their achievements and contribution toward industry and society were evaluated. On the basis of their setup, the organization and laboratories were evaluated to frame-out a SWOT analysis.

SWOT analysis is a deliberate technique carried out to analyze the current situation of the system and to analyze the internal and external environment, which provides and edge to the organization to sustain. The major factors assessed were manpower, machines, money and funding, and achievements and deliverables were studied.

The research, i.e. SWOT, is unique in nature, as it was not carried out earlier on such a scale. To some extent, the points suggested in SWOT and conclusion can be considered on their discretion; however, the organization has raised its position to international standards, but still it can consider few areas/suggestions from this analysis. These points are suggestive and flexible in nature, which are identified and defined to elevate this organization on the globe. Scientific publications do make a difference, but on the ground; if the technologies are not viable and received by public, it makes no difference. Today, India is fortunate to have a Prime Minister like Mr Modi, who always re-evaluates the issues and solutions so that the country moves from developing to a fast-pace developed nation. It is a fact that if these research organizations reorganize themselves and prioritize the research problems, they are capable enough to become a pioneer among the world R&D industry.

In this talk, I propose to cover two areas of intellectual property. These are copyright and patents. I will examine both of these topics in regard to the provision of scientific and technical information and the development of a dynamic and growing electronic information industry. For I believe that any country that plans to have a healthy information industry requires strong and rigorously enforced patent laws, and strong and rigorously enforced copyright laws.

The purpose of this paper is to further the development of strategic thinking, relevant for both academics and practitioners, about a key asset in the knowledge economy: patents.

This paper draws on existing insights on the strategic use of patents, presenting them in a coherent framework.

The paper discusses the different aspects to patent strategizing that need dedicated management attention, and discusses the key considerations to be taken into account. The paper also indicates at which levels in the organization patent strategizing needs to take place.

Practitioners will be much more aware of the strategic options for using patents to further a firm's competitive position.

The paper draws to some extent on existing knowledge about patents. Such knowledge has, however, been scattered across different domains. The strategic options for a firm of using patents have not been discussed at length or in the context of a comprehensive framework either in the academic literature or in that for practitioners.

The purpose of this paper is to study the relationship between open innovation and the use of intellectual property rights (IPRs) in small- and medium-sized enterprises (SMEs). The authors consider patents, industrial designs (i.e. design patents in the USA), trademarks, and copyrights.

The relationships between open innovation, IPRs, and profitability are tested with random-effects panel regressions on data from the Spanish Community Innovation Survey for 2,873 firms spanning the years 2008-2013.

A key result is that SMEs do not benefit from open innovation or from patenting in the same way as larger firms. Furthermore, the results show that SMEs profit in different ways from IPR, depending on their size and the corresponding IPR.

The different impact of IPRs on the efficiency of open innovation in firms of varying sizes highlights the importance of further investigation into IP strategies and into open innovation in SMEs.

Industrial designs are currently the most efficient IPR for SMEs to protect their intellectual property in open innovation collaborations. Depending on the company size, the use of different IPRs is recommended. Moreover, firms should seek to increase the efficiency of open innovation and the use of IPRs.

The high impact of SMEs on employment highlights the importance of fomenting efficient innovation processes in such firms.

This paper opens the black box of IPR in relation to open innovation in SMEs, and draws distinctive conclusions with regards to patents, industrial designs, trademarks, and copyrights.